Large gap with delayed quotes
|
Last quote
04/15/2026
-
23:20:00
|
Bid
04/15/2026 -
21:59:59
|
Bid Volume |
Ask
04/15/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
753.93
-1.58
(
-0.21% )
|
753.56
|
160 |
753.92
|
40 |
Analysis date: 10.04.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.02.2026.
Interest
Weak
Weak
Two stars since 10.04.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 31.03.2026 at a price of 772.64.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 31.03.2026.
4wk Rel Perf
-3.52%
-3.52%
The four-week dividend-adjusted underperformance versus SP500 is 3.52%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 17.02.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.62%.
Mkt Cap in $bn
79.16
79.16
With a market capitalization >$8bn, REGENERON PHARMA is considered a large-cap stock.
G/PE Ratio
1
1
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
12.46
12.46
The estimated PE is for the year 2028.
LT Growth
11.93%
11.93%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
24
24
Over the last seven weeks, an average of 24 analysts provided earnings per share estimates.
Dividend Yield
0.53%
0.53%
The twelve month estimated dividend yield represents 6.63% of earnings forecasts.
Beta
98
98
For 1% of index variation, the stock varies on average by 0.98%.
Correlation
0.32
0.32
Stock movements are strongly independent of index variations.
Value at Risk
142.79
142.79
The value at risk is estimated at USD 142.79. The risk is therefore 19.07%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.04.2004
02.04.2004